Connect Biopharma Holdings (CNTB) Common Equity (2020 - 2026)
Connect Biopharma Holdings (CNTB) reported Common Equity of $26.86 million for Q2 2026, down 62.3% from $71.34 million a year earlier and down 37.0% from the prior quarter.
Powered by 
Analysis
Connect Biopharma Holdings (CNTB) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Connect Biopharma Holdings posted Common Equity of $41.98 million, down 54.5% from FY2024.
- Common Equity has declined for four consecutive years.
- By year, Common Equity came in at $92.17 million in FY2024 (-9.2%), $101.5 million in FY2023 (-35.9%), $158.42 million in FY2022 (-41.8%) and $272.26 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Common Equity since Q4 2020.
- Year over year, Common Equity has now declined in each of the last seven quarters, with an average decline of 38.1% over the last seven quarters.
- The year-over-year decline in Common Equity has ranged between 9.2% (Q4 2024) and 62.3% (Q2 2026) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $42.62 million (Q1 2026), $41.98 million (Q4 2025) and $55.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.61 Bn | 1,103.20 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 616.25 Bn | 534.77 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 501.45 Bn | 474.56 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.44 Bn | 235.12 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 235.87 Bn | 191.27 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Connect Biopharma Holdings | 51.90 Mn | -124.78 Mn | - | 26.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.86 Mn |
| Mar 31, 2026 | 42.62 Mn |
| Dec 31, 2025 | 41.98 Mn |
| Sep 30, 2025 | 55.37 Mn |
| Jun 30, 2025 | 71.34 Mn |
| Mar 31, 2025 | 82.90 Mn |
| Dec 31, 2024 | 92.17 Mn |
| Sep 30, 2024 | 100.65 Mn |
| Jun 30, 2024 | 110.93 Mn |
| Mar 31, 2024 | 93.90 Mn |
| Dec 31, 2023 | 101.50 Mn |
| Jun 30, 2023 | 128.67 Mn |
| Dec 31, 2022 | 157.53 Mn |
| Jun 30, 2022 | 212.99 Mn |
| Dec 31, 2021 | 272.41 Mn |
| Dec 31, 2020 | -157.15 Mn |
API Access
Connect Biopharma Holdings Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CNTB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CNTB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CNTB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();